Showing 20 of 223 recruiting trials for “acute-promyelocytic-leukemia”
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
👨⚕️ Sanbin Wang, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Jun 2024View details ↗
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL
👨⚕️ Jianxiang Wang, Dr, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jun 2024View details ↗
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
A Study to Evaluate the MNV-201 in Patients With Low Risk MDS
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
A Study of GLB-001 in Patients With Myeloid Malignancies
👨⚕️ Gang Lu, Ph.D., Hangzhou GluBio Pharmaceutical Co., Ltd.📍 14 sites📅 Started May 2024View details ↗
Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Vitamin A and D Supplementation in Allogeneic HCT
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL
👨⚕️ Xiaowen Tang, Ph.D, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Apr 2024View details ↗
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
RecruitingNCT06025682 ↗
Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO
👨⚕️ Livio Pagano, Policlinico Universitario A. Gemelli, IRCCS-Università Cattolica del Sacro Cuore, Roma📍 1 site📅 Started Apr 2024View details ↗
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
👨⚕️ Amber Afzal, M.D., MSCI, Washington University School of Medicine📍 1 site📅 Started Feb 2024View details ↗
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
👨⚕️ Aimee C. Talleur, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Feb 2024View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →